Acquired EML4-ALK Fusion and EGFR C797S in Cis Mutation As Resistance Mechanisms to Osimertinib in a Non-Small Cell Lung Cancer Patient with EGFR L858R/T790M
ANTI-CANCER DRUGS（2023）
Key words
C797S mutation,epidermal growth factor receptor tyrosine kinase inhibitors,EML4-ALK,osimertinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined